We offer extracorporeal membrane oxygenation (ECMO) treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we develop extracorporeal life support (ECLS) technologies that can be vital for the survival of critically ill patients.[1-3]

We provide solutions that combine both cardiac and pulmonary support on one single technological platform, the Xenios console. It supports gas exchange in the lungs and the cardiovascular system. ECMO thus provides physicians with crucial time for diagnosis and therapy.[1]

Extracorporeal life support with ECMO - Essential treatment time for doctors and patients
Multiorgan support Fresenius Medical Care

Xenios is part of Fresenius Medical Care, the world’s leading provider of products and services for people with renal diseases. As human organs are a mutually linked system, Fresenius Medical Care pursues a multi-organ support approach in Critical Care, drawing on its extensive expertise in extracorporeal blood treatment for acute kidney injury.

We are complementing Fresenius Medical Care’s product portfolio in the field of intensive care and are continuing to shape the future of extracorporeal multi-organ support.

In our daily work, we share a passion for helping people.
For patients. Worldwide. Every day.



Find the right person for your topic with our contact form.

Heart & Lung Campus

Join, Learn, Care

Looking for further treatment and product information?

Join our Heart & Lung Campus to explore various e-learning modules, for example expert interviews, best-practice-cases, medical information, hands-on-tutorials and priming instructions.

On demand, 24 hours a day, 7 days a week – whenever you need it.


ESPNIC congress 2024

20. June 2024

A heartfelt thank you to all ESPNIC congress 2024 and symposium attendees! Our deepest gratitude to everyone who participated in the ESPNIC congress 2024 and the accompanying lunch symposium. Your presence, engagement, and contributions made this event an outstanding success! It was an honor to connect with so many dedicated healthcare ...


EuroELSO congress 2024

21. May 2024

Thanks for an amazing EuroELSO congress! We shared new insights, had great conversations and enjoyed spending time in Krakow. See you next year!

ISICEM congress 2024

25. March 2024

Thanks for a great ISICEM congress 2024! We had a lot of interesting conversations and industry insights. See you next year!  


28. September – 01. October
US ELSO Conference 2024

35th Annual ELSO Conference

Location: Detroit

05. – 09. October

37th ESICM's (European Society Of Intensive Care Medicine) annual congress - LIVES

Visit our Critical Care booth!

09. – 12. October
EACTS 2024

38th EACTS (European Association for Cardio-Thoracic Surgery) Annual Meeting


Lisbon Congress Centre (CCL), Portugal

[1] ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support. Extracorporeal Life Support Organization, Version 1.4 August 2017, Ann Arbor, MI, USA

[2] Peek, G. et al. (2009). Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet, 374(9698), 1351–1363

[3] Combes, A. et al. (2018). Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med, 378(21), 1965–1975